Viridian Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 141K | 132K | 70.6M | 75K | 72K | 72K | 86K | 72K |
| Cost of Goods Sold | 121K | 320K | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 20K | -188K | 70.6M | 75K | 72K | 72K | 86K | 72K |
| R&D Expenses | 77.6M | 89.2M | 86.3M | 86.6M | 76.8M | 72.0M | 69.2M | 56.2M |
| Operating Expenses | 116.2M | 122.6M | 110.6M | 106.8M | 93.9M | 87.5M | 83.6M | 72.3M |
| Operating Income | -116.2M | -122.7M | -40.0M | -106.8M | -93.9M | -87.5M | -83.5M | -72.2M |
| Other Income / Gains | 11.3M | 2.4M | 5.4M | 6.0M | 7.0M | 7.7M | 6.8M | 7.2M |
| Net Income | -104.9M | -120.4M | -34.6M | -100.7M | -86.9M | -79.7M | -76.7M | -65.0M |
| EPS (Diluted) | -1.03 | -1.11 | -0.34 | -1.00 | -0.87 | -0.81 | -1.15 | -1.02 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.142 | -1.424 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| General And Administrative Expenses | 0 | 33.7M | 24.3M | 20.2M | 17.1M | 15.6M | 14.4M | 16.1M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 38.7M | 33.7M | 24.3M | 20.2M | 17.1M | 15.6M | 14.4M | 16.1M |
| Other Expenses | 0 | -320K | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 116.3M | 122.9M | 110.6M | 106.8M | 93.9M | 87.5M | 83.6M | 72.3M |
| Interest Income | 7.9M | 7.8M | 5.5M | 6.5M | 7.5M | 8.6M | 7.8M | 7.8M |
| Interest Expense | 3.5M | 6.6M | 560K | 514K | 586K | 858K | 1.0M | 597K |
| Depreciation And Amortization | 121K | -340K | 110K | 113K | 117K | 123K | 130K | 142K |
| Ebitda | -101.3M | -114.1M | -33.9M | -100.1M | -86.2M | -78.7M | -75.6M | -64.3M |
| Ebitdaratio | -718.567 | -864.295 | -0.481 | -1K | -1K | -1K | -878.547 | -892.417 |
| Operating Income Ratio | -823.894 | -929.917 | -0.567 | -1K | -1K | -1K | -970.698 | -1K |
| Income Before Tax | -104.9M | -120.4M | -34.6M | -100.7M | -86.9M | -79.7M | -76.7M | -65.0M |
| Income Before Tax Ratio | -743.979 | -911.78 | -0.49 | -1K | -1K | -1K | -891.733 | -902.681 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | -743.979 | -911.78 | -0.49 | -1K | -1K | -1K | -891.733 | -902.681 |
| Epsdiluted | -1.03 | -1.11 | -0.34 | -1.00 | -0.87 | -0.81 | -1.15 | -1.02 |
| Weighted Average Shs Out | 102.2M | 84.8M | 81.8M | 81.6M | 81.3M | 80.1M | 66.4M | 63.9M |
| Weighted Average Shs Out Dil | 102.2M | 84.8M | 81.8M | 81.6M | 81.3M | 80.1M | 66.4M | 63.9M |